- Home
- EVR vs PEN Comparison
EVR vs PEN Comparison
Compare EVR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVR
- PEN
- Stock Information
- Founded
- EVR 1995
- PEN 2004
- Country
- EVR United States
- PEN United States
- Employees
- EVR N/A
- PEN N/A
- Industry
- EVR Investment Managers
- PEN Medical/Dental Instruments
- Sector
- EVR Finance
- PEN Health Care
- Exchange
- EVR Nasdaq
- PEN Nasdaq
- Market Cap
- EVR 10.8B
- PEN 9.1B
- IPO Year
- EVR 2006
- PEN 2015
- Fundamental
- Price
- EVR $287.60
- PEN $268.17
- Analyst Decision
- EVR Hold
- PEN Buy
- Analyst Count
- EVR 6
- PEN 16
- Target Price
- EVR $289.60
- PEN $262.87
- AVG Volume (30 Days)
- EVR 329.4K
- PEN 423.0K
- Earning Date
- EVR 01-29-2025
- PEN 02-20-2025
- Dividend Yield
- EVR 1.12%
- PEN N/A
- EPS Growth
- EVR N/A
- PEN N/A
- EPS
- EVR 7.79
- PEN 0.89
- Revenue
- EVR $2,789,086,000.00
- PEN $1,163,776,000.00
- Revenue This Year
- EVR $21.02
- PEN $13.55
- Revenue Next Year
- EVR $23.19
- PEN $14.48
- P/E Ratio
- EVR $36.92
- PEN $302.85
- Revenue Growth
- EVR 12.78
- PEN 16.96
- 52 Week Low
- EVR $168.04
- PEN $148.00
- 52 Week High
- EVR $324.06
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- EVR 57.00
- PEN 68.37
- Support Level
- EVR $257.35
- PEN $237.65
- Resistance Level
- EVR $283.49
- PEN $260.88
- Average True Range (ATR)
- EVR 6.21
- PEN 9.75
- MACD
- EVR 1.91
- PEN 2.18
- Stochastic Oscillator
- EVR 94.15
- PEN 94.76
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,200 employees at the end of 2023, and about 75% of its revenue is derived from the United States.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.